Ganesh Kambhampati is a Nephrology physician. OpenAlex indexes 14 publications with 446 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
520 Cottonwood St Ste 2
Woodland, CA 956953603
Telephone
530-668-3600Provider last certified this registry record 13 Jun 2025.
Clinical trials
- Fluid Balance and Clinical Outcomes
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20241 payment
- Amgen Inc.Program year20241 payment
- Travere Therapeutics, Inc.Program year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
43.7%Vitamin D3 Analog37.1%Calcitriol100%Part D≥159 patientsProvitamin D2 Compound2.9%Vitamin D2100%Part D≥19 patients+ 3 more classes in this area
Cardiovascular
33.1%Loop diuretic6.9%Furosemide100%Part D≥36 patientsBeta blocker4.7%Metoprolol Tartrate52%Metoprolol Succinate24%Carvedilol23%Part D<11 patients+ 8 more classes in this area
Musculoskeletal
9.1%Xanthine oxidase inhibitor9.1%Allopurinol100%Part D≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Update on clinical trials for the prevention of acute kidney injury in patients undergoing cardiac surgery
The American Journal of Surgery
2013 - Fluid balance and conventional and novel biomarkers of acute kidney injury in cardiovascular surgery.
PubMed
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”